tetano
Editor, Senior Moderator
J Epidemiol Glob Health
. 2021 Oct 28;1-13.
doi: 10.1007/s44197-021-00009-1. Online ahead of print.
Age-Specific Etiology of Severe Acute Respiratory Infections and Influenza Vaccine Effectivity in Prevention of Hospitalization in Russia, 2018-2019 Season
Anna Sominina[SUP] 1 [/SUP], Daria Danilenko[SUP] 2 [/SUP], Andrey Komissarov[SUP] 2 [/SUP], Maria Pisareva[SUP] 2 [/SUP], Tamila Musaeva[SUP] 2 [/SUP], Mikhail Bakaev[SUP] 2 [/SUP], Olga Afanasieva[SUP] 2 [/SUP], Kirill Stolyarov[SUP] 2 [/SUP], Elizaveta Smorodintseva[SUP] 2 [/SUP], Elena Rozhkova[SUP] 2 [/SUP], Elena Obraztsova[SUP] 2 [/SUP], Elena Dondurey[SUP] 2 [/SUP], Dmitry Guzhov[SUP] 2 [/SUP], Veronica Timonina[SUP] 3 [/SUP], Ekaterina Golovacheva[SUP] 2 [/SUP], Olga Kurskaya[SUP] 4 [/SUP], Alexander Shestopalov[SUP] 4 [/SUP], Svetlana Smirnova[SUP] 5 [/SUP], Alexander Alimov[SUP] 5 [/SUP], Dmitry Lioznov[SUP] 2 [/SUP]
Affiliations
Abstract
The expansion and standardization of clinical trials, as well as the use of sensitive and specific molecular diagnostics methods, provide new information on the age-specific roles of influenza and other respiratory viruses in development of severe acute respiratory infections (SARI). Here, we present the results of the multicenter hospital-based study aimed to detect age-specific impact of influenza and other respiratory viruses (ORV). The 2018-2019 influenza season in Russia was characterized by co-circulation of influenza A(H1N1)pdm09 and A(H3N2) virus subtypes which were detected among hospitalized patients with SARI in 19.3% and 16.4%, respectively. RSV dominated among ORV (15.1% of total cases and 26.8% in infants aged ≤ 2 years). The most significant SARI agents in intensive care units were RSV and influenza A(H1N1)pdm09 virus, (37.3% and 25.4%, respectively, of PCR-positive cases). Hyperthermia was the most frequently registered symptom for influenza cases. In contrast, hypoxia, decreased blood O[SUB]2[/SUB] concentration, and dyspnea were registered more often in RSV, rhinovirus, and metapneumovirus infection in young children. Influenza vaccine effectiveness (IVE) against hospitalization of patients with PCR-confirmed influenza was evaluated using test-negative case-control design. IVE for children and adults was estimated to be 57.0% and 62.0%, respectively. Subtype specific IVE was higher against influenza A(H1N1)pdm09, compared to influenza A(H3N2) (60.3% and 45.8%, respectively). This correlates with delayed antigenic drift of the influenza A(H1N1)pdm09 virus and genetic heterogeneity of the influenza A(H3N2) population. These studies demonstrate the need to improve seasonal influenza prevention and control in all countries as states by the WHO Global Influenza Strategy for 2019-2030 initiative.
Keywords: Hospitalization; Influenza; Respiratory viruses; Vaccine effectiveness.
. 2021 Oct 28;1-13.
doi: 10.1007/s44197-021-00009-1. Online ahead of print.
Age-Specific Etiology of Severe Acute Respiratory Infections and Influenza Vaccine Effectivity in Prevention of Hospitalization in Russia, 2018-2019 Season
Anna Sominina[SUP] 1 [/SUP], Daria Danilenko[SUP] 2 [/SUP], Andrey Komissarov[SUP] 2 [/SUP], Maria Pisareva[SUP] 2 [/SUP], Tamila Musaeva[SUP] 2 [/SUP], Mikhail Bakaev[SUP] 2 [/SUP], Olga Afanasieva[SUP] 2 [/SUP], Kirill Stolyarov[SUP] 2 [/SUP], Elizaveta Smorodintseva[SUP] 2 [/SUP], Elena Rozhkova[SUP] 2 [/SUP], Elena Obraztsova[SUP] 2 [/SUP], Elena Dondurey[SUP] 2 [/SUP], Dmitry Guzhov[SUP] 2 [/SUP], Veronica Timonina[SUP] 3 [/SUP], Ekaterina Golovacheva[SUP] 2 [/SUP], Olga Kurskaya[SUP] 4 [/SUP], Alexander Shestopalov[SUP] 4 [/SUP], Svetlana Smirnova[SUP] 5 [/SUP], Alexander Alimov[SUP] 5 [/SUP], Dmitry Lioznov[SUP] 2 [/SUP]
Affiliations
- PMID: 34734387
- PMCID: PMC8552611
- DOI: 10.1007/s44197-021-00009-1
Abstract
The expansion and standardization of clinical trials, as well as the use of sensitive and specific molecular diagnostics methods, provide new information on the age-specific roles of influenza and other respiratory viruses in development of severe acute respiratory infections (SARI). Here, we present the results of the multicenter hospital-based study aimed to detect age-specific impact of influenza and other respiratory viruses (ORV). The 2018-2019 influenza season in Russia was characterized by co-circulation of influenza A(H1N1)pdm09 and A(H3N2) virus subtypes which were detected among hospitalized patients with SARI in 19.3% and 16.4%, respectively. RSV dominated among ORV (15.1% of total cases and 26.8% in infants aged ≤ 2 years). The most significant SARI agents in intensive care units were RSV and influenza A(H1N1)pdm09 virus, (37.3% and 25.4%, respectively, of PCR-positive cases). Hyperthermia was the most frequently registered symptom for influenza cases. In contrast, hypoxia, decreased blood O[SUB]2[/SUB] concentration, and dyspnea were registered more often in RSV, rhinovirus, and metapneumovirus infection in young children. Influenza vaccine effectiveness (IVE) against hospitalization of patients with PCR-confirmed influenza was evaluated using test-negative case-control design. IVE for children and adults was estimated to be 57.0% and 62.0%, respectively. Subtype specific IVE was higher against influenza A(H1N1)pdm09, compared to influenza A(H3N2) (60.3% and 45.8%, respectively). This correlates with delayed antigenic drift of the influenza A(H1N1)pdm09 virus and genetic heterogeneity of the influenza A(H3N2) population. These studies demonstrate the need to improve seasonal influenza prevention and control in all countries as states by the WHO Global Influenza Strategy for 2019-2030 initiative.
Keywords: Hospitalization; Influenza; Respiratory viruses; Vaccine effectiveness.